These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8955224)

  • 1. The balance between persistent virus infection and immune cells determines demyelination.
    Rodriguez M; Pavelko KD; Njenga MK; Logan WC; Wettstein PJ
    J Immunol; 1996 Dec; 157(12):5699-709. PubMed ID: 8955224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
    Gerety SJ; Rundell MK; Dal Canto MC; Miller SD
    J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CD4+ and CD8+ T cells in demyelinating disease following Theiler's virus infection: a model for multiple sclerosis.
    Rodriguez M; Rivera-Quinones C; Murray PD; Kariuki Njenga M; Wettstein PJ; Mak T
    J Neurovirol; 1997 May; 3 Suppl 1():S43-5. PubMed ID: 9179791
    [No Abstract]   [Full Text] [Related]  

  • 4. Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease. Evidence for a CD4+ T cell-mediated pathology.
    Pope JG; Karpus WJ; VanderLugt C; Miller SD
    J Immunol; 1996 May; 156(10):4050-8. PubMed ID: 8621948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations.
    Rodriguez M; Roos RP; McGavern D; Zoecklein L; Pavelko K; Sang H; Lin X
    Virology; 2000 Sep; 275(1):9-19. PubMed ID: 11017783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity.
    Lin X; Pease LR; Murray PD; Rodriguez M
    J Immunol; 1998 Jun; 160(11):5661-8. PubMed ID: 9605173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptively transferred CD8+ T lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice.
    Nicholson SM; Dal Canto MC; Miller SD; Melvold RW
    J Immunol; 1996 Feb; 156(3):1276-83. PubMed ID: 8558008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of CD4+ T cell-mediated apoptosis of activated astrocytes in Theiler's virus-induced demyelination.
    Palma JP; Yauch RL; Lang S; Kim BS
    J Immunol; 1999 Jun; 162(11):6543-51. PubMed ID: 10352270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.
    Bowen JL; Olson JK
    J Immunol; 2009 Dec; 183(11):6971-80. PubMed ID: 19890055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin.
    Rodriguez M; Dunkel AJ; Thiemann RL; Leibowitz J; Zijlstra M; Jaenisch R
    J Immunol; 1993 Jul; 151(1):266-76. PubMed ID: 8326128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis.
    Murray PD; Pavelko KD; Leibowitz J; Lin X; Rodriguez M
    J Virol; 1998 Sep; 72(9):7320-9. PubMed ID: 9696828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
    Bristol JA; Schlom J; Abrams SI
    Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CD4+ and CD8+ T lymphocytes in the protection of mice against Encephalitozoon intestinalis infection.
    Salát J; Braunfuchsová P; Kopecký J; Ditrich O
    Parasitol Res; 2002 Jul; 88(7):603-8. PubMed ID: 12107451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the mechanisms by which CD4+ T cells contribute to protection in Theiler's murine encephalomyelitis.
    Borrow P; Welsh CJ; Nash AA
    Immunology; 1993 Nov; 80(3):502-6. PubMed ID: 7904593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response is required for protection from Theiler's virus-induced encephalitis in C57BL/6 mice in the absence of CD8+ T cells.
    Kang BS; Palma JP; Lyman MA; Dal Canto M; Kim BS
    Virology; 2005 Sep; 340(1):84-94. PubMed ID: 16039687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Fluorouracil and levamisole exacerbate demyelination in susceptible mice infected with Theiler's virus.
    Lucchinetti CF; Kimmel DW; Pavelko K; Rodriguez M
    Exp Neurol; 1997 Sep; 147(1):123-9. PubMed ID: 9294409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis.
    Rodriguez M; Pavelko KD; McKinney CW; Leibowitz JL
    J Immunol; 1994 Oct; 153(8):3811-21. PubMed ID: 7930598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus.
    Paya CV; Patick AK; Leibson PJ; Rodriguez M
    J Immunol; 1989 Jul; 143(1):95-102. PubMed ID: 2543704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alpha/beta mediates early virus-induced expression of H-2D and H-2K in the central nervous system.
    Njenga MK; Pease LR; Wettstein P; Mak T; Rodriguez M
    Lab Invest; 1997 Jul; 77(1):71-84. PubMed ID: 9251680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.
    Osorio Y; La Point SF; Nusinowitz S; Hofman FM; Ghiasi H
    Exp Neurol; 2005 May; 193(1):1-18. PubMed ID: 15817260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.